GREWAL; Iqbal

Patent Applications and Registrations

Patent applications and USPTO patent grants for GREWAL; Iqbal.The latest application filed is for "chimeric antigen receptor system and uses thereof".

Company Profile

1.8.22

GREWAL; Iqbal - Newtown PA
Grewal; Iqbal - Chalfont PA
GREWAL; Iqbal - Redwood City CA
Grewal; Iqbal - Snohomish WA US
Grewal; Iqbal - Fremont CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chimeric Antigen Receptor System And Uses Thereof App 20220305056 - GANESAN; Rajkumar ; et al.	2022-09-29
Engineered antibody-interferon mutant fusion molecules Grant 10,259,854 - Grewal , et al.	2019-04-16
Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases Grant 9,783,589 - Grewal , et al. October 10, 2	2017-10-10
Combination Therapy App 20170233482 - GREWAL; Iqbal	2017-08-17
Engineered Antibody-interferon Mutant Fusion Molecules App 20170073388 - Grewal; Iqbal ; et al.	2017-03-16
Methods of treating tumors with engineered antibody-interferon mutant fusion molecules Grant 9,534,057 - Grewal , et al. January 3, 2	2017-01-03
Engineered TAA antibody-TNFSF member ligand fusion molecules Grant 9,534,056 - Grewal , et al. January 3, 2	2017-01-03
Engineered Antibody-interferon Fusion Molecules For Treatment Of Autoimmune Diseases App 20150203560 - Grewal; Iqbal ; et al.	2015-07-23
Engineered Antibody-interferon Mutant Fusion Molecules App 20150139951 - Grewal; Iqbal ; et al.	2015-05-21
Engineered antibody-interferon mutant fusion molecules Grant 8,980,267 - Grewal , et al. March 17, 2	2015-03-17
Engineered Antibody-tnfsf Member Ligand Fusion Molecules App 20140105860 - Grewal; Iqbal ; et al.	2014-04-17
Engineered Antibody-interferon Mutant Fusion Molecules App 20130230517 - GREWAL; IQBAL ; et al.	2013-09-05
Combination Therapy App 20110123531 - GREWAL; Iqbal	2011-05-26
Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases App 20110097325 - de Sauvage; Frederic J. ; et al.	2011-04-28
Compositions And Methods For The Treatment Of Immune Related Diseases App 20090017014 - Valdez; Patricia A. ; et al.	2009-01-15
Novel Gene Disruptions, Composition and Methods Relating Thereto App 20080305106 - Brennan; Jane ; et al.	2008-12-11
Compositions and methods for the treatment of immune related diseases Grant 7,419,799 - Valdez , et al. September 2, 2	2008-09-02
Taci Antibodies And Uses Thereof App 20080171036 - Chuntharapai; Anan ; et al.	2008-07-17
Modulation of T cell differentiation for the treatment of T helper cell mediated diseases Grant 7,393,532 - de Sauvage , et al. July 1, 2	2008-07-01
Combination Therapy App 20070178091 - Grewal; Iqbal	2007-08-02
Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases App 20070134238 - de Sauvage; Frederic J. ; et al.	2007-06-14
Uses of agonists and antagonists to modulate activity of TNF-related molecules App 20060073146 - Ashkenazi; Avi J. ; et al.	2006-04-06
Taci and br3 polypeptides and uses thereof App 20050070689 - Dixit, Vishva ; et al.	2005-03-31
TACI antibodies and uses thereof App 20050043516 - Chuntharapai, Anan ; et al.	2005-02-24
Uses of opg to modulate immune responses App 20050031583 - Grewal, Iqbal	2005-02-10
Type I cytokine receptor TCCR App 20040234522 - DeSauvage, Frederic ; et al.	2004-11-25
Compositions and methods for the treatment of immune related diseases App 20030099661 - Valdez, Patricia A. ; et al.	2003-05-29
Combination therapy App 20020197256 - Grewal, Iqbal	2002-12-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.